# Secoisolariciresinol

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/secoisolariciresinol
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 6 / 10
**Category:** Compound
**Also Known As:** Secoisolariciresinol diglucoside, SDG, Flax lignan, Linseed lignan, Hydroxymatairesinol precursor, Plant lignan extract

## Overview

Secoisolariciresinol is a plant lignan found primarily in flaxseeds that converts to enterolignans in the [gut microbiome](/ingredients/condition/gut-health). It reduces cholesterol through HMG-CoA reductase inhibition and may lower breast cancer risk by modulating estrogen [metabolism](/ingredients/condition/weight-management).

## Health Benefits

• May reduce [LDL cholesterol](/ingredients/condition/heart-health) in men: A 2024 RCT showed significant reduction in LDL-C and total cholesterol in men taking 60mg/day for 12 weeks (moderate evidence)
• Potential breast cancer risk reduction: A Phase IIB RCT found SDG reduced Ki-67 proliferation marker by 2.2% in premenopausal high-risk women (preliminary evidence)
• [Anti-inflammatory](/ingredients/condition/inflammation) effects: Preclinical studies show SDG activates Nrf2/HO-1 pathway while inhibiting NF-κB (animal evidence only)
• Cardiovascular support: Animal studies suggest ACE inhibition properties, though human confirmation lacking (preliminary evidence)
• [Antioxidant activity](/ingredients/condition/antioxidant): Metabolites enterodiol and enterolactone demonstrate antioxidant effects through multiple pathways (mechanistic evidence)

## Mechanism of Action

Secoisolariciresinol diglucoside (SDG) is converted by gut bacteria into enterolignans enterodiol and enterolactone, which act as selective estrogen receptor modulators (SERMs). These metabolites inhibit HMG-CoA reductase, reducing cholesterol synthesis, and compete with endogenous estrogens at estrogen receptors. The compound also modulates aromatase activity and enhances sex hormone-binding globulin production.

## Clinical Summary

A 2024 randomized controlled trial demonstrated that 60mg daily secoisolariciresinol significantly reduced [LDL cholesterol](/ingredients/condition/heart-health) and total cholesterol in men over 12 weeks, representing moderate-quality evidence. A Phase IIB randomized trial found SDG reduced Ki-67 proliferation markers by 2.2% in premenopausal women at high breast cancer risk. However, evidence remains limited with small sample sizes and short-term follow-up periods. More large-scale, long-term studies are needed to confirm therapeutic efficacy.

## Nutritional Profile

Secoisolariciresinol (SDG) is a pure lignan compound, not a whole food, so traditional macronutrient/micronutrient profiling does not apply. As an isolated phytochemical compound: Molecular weight: 362.46 g/mol. Chemical class: Plant lignan (dibenzylbutanediol). Not a source of calories, protein, fat, fiber, vitamins, or minerals in supplemental form. Bioactive compound concentration in common dietary sources: flaxseed is the richest known source at 75–800 mg SDG per 100g dry weight (varies by variety and processing); sesame seeds contain ~29–37 mg/100g; sunflower seeds ~0.6 mg/100g; rye bread ~0.07–0.09 mg/100g. In supplement form, standardized flaxseed lignans typically deliver 50–600 mg SDG per dose. Bioavailability notes: SDG is not absorbed intact; gut microbiota convert SDG to enterolignans enterodiol (ED) and enterolactone (EL), which are the primary circulating bioactive forms. Conversion efficiency varies significantly based on [gut microbiome](/ingredients/condition/gut-health) composition, antibiotic use, and diet. Peak plasma enterolignans reached approximately 8–10 hours post-ingestion. Fat co-ingestion may modestly improve absorption. Enterolactone plasma concentrations after 60 mg/day SDG supplementation in RCT conditions reached approximately 20–40 nmol/L. SDG also exhibits weak phytoestrogenic activity via its enterolignan metabolites, with affinity for estrogen receptor beta (ERβ) >> ERα.

## Dosage & Preparation

Clinically studied doses range from 50-60mg/day of pure SDG compound. [Cardiovascular](/ingredients/condition/heart-health) effects: 60mg/day (as 2x30mg capsules) for 12 weeks. Breast cancer risk reduction: 50mg/day standardized extract for 12 months. Flaxseed sources provide 10-30mg SDG per 30g serving. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Secoisolariciresinol is generally well-tolerated with minimal reported adverse effects in clinical trials. Due to its estrogenic activity, it may interact with hormone replacement therapy and tamoxifen, potentially altering their effectiveness. Women with hormone-sensitive conditions like breast or endometrial cancer should consult healthcare providers before use. Safety during pregnancy and lactation has not been established, so avoidance is recommended.

## Scientific Research

Two key human RCTs have evaluated SDG: a 2024 trial (PMC11111469) with 74 participants showing [LDL cholesterol](/ingredients/condition/heart-health) reduction in men at 60mg/day, and a 2020 Phase IIB trial (PMID: 32312713) with 180 premenopausal women showing modest Ki-67 reduction at 50mg/day. No meta-analyses were identified, and other studies remain preclinical.

## Historical & Cultural Context

While SDG-specific traditional use lacks strong evidence, flaxseed has been consumed for millennia in Western and Ayurvedic traditions for [digestive health](/ingredients/condition/gut-health) and [inflammation](/ingredients/condition/inflammation). Modern focus on isolated SDG stems from 1990s flaxseed research rather than historical lignan isolation.

## Synergistic Combinations

Omega-3 fatty acids, vitamin E, [probiotic](/ingredients/condition/gut-health)s, green tea extract, resveratrol

## Frequently Asked Questions

### What foods contain secoisolariciresinol naturally?

Flaxseeds contain the highest concentrations of secoisolariciresinol diglucoside (SDG), with approximately 75-800mg per 100g depending on variety. Sesame seeds, sunflower seeds, and whole grains contain smaller amounts.

### How much secoisolariciresinol should I take daily?

Clinical studies have used 60mg daily for cholesterol reduction in men over 12 weeks. However, optimal dosing varies by individual and health goals, so consultation with a healthcare provider is recommended.

### Does secoisolariciresinol work the same in men and women?

Research suggests gender differences in response, with cholesterol-lowering effects demonstrated specifically in men. Women may experience different benefits related to estrogen modulation and breast cancer risk reduction due to hormonal differences.

### How long does secoisolariciresinol take to show effects?

Cholesterol-lowering effects were observed after 12 weeks of supplementation in clinical trials. However, enterolactone levels in blood can increase within days to weeks of starting supplementation.

### Can secoisolariciresinol interact with blood thinners?

While direct interactions with anticoagulants haven't been extensively studied, lignans may theoretically affect platelet function. Patients taking warfarin or other blood thinners should monitor INR levels and consult their physician.

### What is the evidence quality for secoisolariciresinol's effects on cholesterol?

A 2024 randomized controlled trial demonstrated that 60mg/day of secoisolariciresinol reduced LDL cholesterol and total cholesterol in men over 12 weeks, providing moderate-level evidence for this effect. However, most existing research focuses on lignan-rich foods rather than isolated secoisolariciresinol, so more studies are needed to confirm efficacy across diverse populations. The current evidence is strongest for men, with limited data in women or other demographic groups.

### Who should consider taking secoisolariciresinol supplements and why?

Men with elevated LDL cholesterol may benefit from secoisolariciresinol supplementation based on recent clinical trial evidence, though consultation with a healthcare provider is recommended before starting. Premenopausal women at high risk for breast cancer may be candidates for supplementation given preliminary findings on proliferation markers, though this research is still in early stages. Individuals with inflammatory conditions may also be candidates, as preclinical studies suggest secoisolariciresinol has anti-inflammatory properties, though human clinical data remains limited.

### How does secoisolariciresinol's bioavailability relate to its source (flaxseed vs. supplement form)?

Secoisolariciresinol (SDG) exists primarily as a precursor in whole flaxseeds, requiring gut bacteria to convert it into active lignan metabolites, which may reduce absorption efficiency compared to isolated supplement forms. Ground or processed flaxseed generally provides better bioavailability than whole seeds due to improved digestive access. Isolated secoisolariciresinol supplements may offer more consistent dosing, though direct comparative studies between food sources and supplement forms are limited.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*